← Back to Clinical Trials
Recruiting NCT06528132

NCT06528132 Social Worker-led Mindfulness-based Intervention for Older People

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06528132
Status Recruiting
Phase
Sponsor The University of Hong Kong
Condition Depressive Symptoms
Study Type INTERVENTIONAL
Enrollment 207 participants
Start Date 2024-07-23
Primary Completion 2026-03-16

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Mindfulness-based intervention (MBI) (enhanced with peer supporters)Experimental: social worker-led MBI (without peer supporters)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 207 participants in total. It began in 2024-07-23 with a primary completion date of 2026-03-16.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Preliminary findings from a previous study conducted by the investigators suggest that a task-shared approach with modified mindfulness-based cognitive therapy (MBCT) supported by social workers is beneficial in managing depressive symptoms and improving mindful non-reactivity among older adults. However, the possibility for social workers to lead a mindfulness-based intervention (MBI) independently to improve its scalability and service accessibility remains unclear. The project aims to: 1. Evaluate the effectiveness of social worker-led MBI in improving depression in older adults with mild to moderate depressive symptoms as compared to care as usual; 2. Examine the effectiveness of incorporating peer supporters in social worker-led MBI compared to those without peer supporters; 3. To identify potential mechanisms of change in MBI for depressive symptoms.

Eligibility Criteria

Inclusion Criteria: * 60 years or older * have depressive symptoms of mild level or above, as indicated by scoring 5-14 on PHQ-9 * can give informed consent to participate Exclusion Criteria: * known history of autism, intellectual disability, schizophrenia-spectrum disorder, bipolar disorder, Parkinson's disease, or dementia * current abuse of drugs or alcohol * difficulty in communication * imminent suicidal risk * timing or training is unsuitable for the participant

Contact & Investigator

Central Contact

Dara KY Leung, PhD

✉ daralky@hku.hk

📞 3917-0081

Principal Investigator

Terry YS Lum, PhD

PRINCIPAL INVESTIGATOR

Department of Social Work and Social Administration, The University of Hong Kong

Frequently Asked Questions

Who can join the NCT06528132 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Depressive Symptoms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06528132 currently recruiting?

Yes, NCT06528132 is actively recruiting participants. Contact the research team at daralky@hku.hk for enrollment information.

Where is the NCT06528132 trial being conducted?

This trial is being conducted at Eastern District, Hong Kong, Kowloon City, Hong Kong, Kowloon City, Hong Kong, Kwun Tong, Hong Kong and 9 additional locations.

Who is sponsoring the NCT06528132 clinical trial?

NCT06528132 is sponsored by The University of Hong Kong. The principal investigator is Terry YS Lum, PhD at Department of Social Work and Social Administration, The University of Hong Kong. The trial plans to enroll 207 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology